Cargando…
Renovascular and renoprotective properties of telmisartan: clinical utility
Chronic kidney disease (CKD) affects approximately 26 million adults in the United States and millions of others are at increased risk. Type 2 diabetes and hypertension are the two main causes of CKD. Blood pressure control is critical to slow the progression of CKD. Despite adequate control, howeve...
Autores principales: | Ladino, Marco, Schulman, Ivonne Hernandez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108769/ https://www.ncbi.nlm.nih.gov/pubmed/21694926 |
Ejemplares similares
-
Renoprotective effects of telmisartan after unilateral renal ablation in rats
por: Matsuo, Tomohiro, et al.
Publicado: (2013) -
Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011) -
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
por: López-Novoa, José M, et al.
Publicado: (2011) -
Renovascular hypertension in children
por: Patel, Premal Amrishkumar, et al.
Publicado: (2021) -
Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)